Cargando…

Mobile PCR-based surveillance for SARS-CoV-2 to reduce visiting restrictions in nursing homes during the COVID-19 pandemic: a pilot study

PURPOSE: Residents in nursing homes for the elderly (NH) are at high risk for death from COVID-19. We investigated whether repeated non-mandatory RT-PCR SARS-CoV-2 surveillance of NH staff and visitors reduces COVID-19 incidence rates in NH residents and allows to reduce visiting restrictions. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stemler, Jannik, Kramer, Theresa, Dimitriou, Vassiliki, Wieland, Ulrike, Schumacher, Sofie, Sprute, Rosanne, Oberste, Max, Wiesmüller, Gerhard, Rau, Harald, Pieper, Sally, Bethe, Ullrich, Lehmann, Clara, Hellmich, Martin, Klein, Florian, Langebartels, Georg, Cornely, Oliver A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527812/ https://www.ncbi.nlm.nih.gov/pubmed/34669164 http://dx.doi.org/10.1007/s15010-021-01716-4

Ejemplares similares

EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections
por: Sprute, Rosanne, et al.
Publicado: (2022)

Web-based, rapid and contactless management of ambulatory patients for SARS-CoV-2-testing
por: Stemler, Jannik, et al.
Publicado: (2021)

Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2
por: Sprute, Rosanne, et al.
Publicado: (2021)

Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching
por: Grothe, Jan, et al.
Publicado: (2022)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network
por: Neuhann, Julia M., et al.
Publicado: (2022)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
por: Sprute, Rosanne, et al.
Publicado: (2021)

Reason and reality—identifying barriers to patient enrolment for clinical trials in invasive candidiasis
por: Sprute, Rosanne, et al.
Publicado: (2022)

The silent flucytosine shortage in Europe – not a distant problem
por: Sprute, Rosanne, et al.
Publicado: (2023)

Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope(®) registry and literature reports
por: Sprute, Rosanne, et al.
Publicado: (2020)

Das Geschlecht in der Infektiologie – wie Geschlechtsunterschiede die Immunantwort auf Infektionen beeinflussen
por: Horn, Carola, et al.
Publicado: (2023)

Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma
por: Stemler, Jannik, et al.
Publicado: (2020)

EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence
por: Stemler, Jannik, et al.
Publicado: (2021)

Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope(®) and the literature
por: Sprute, Rosanne, et al.
Publicado: (2021)

All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections
por: Sprute, Rosanne, et al.
Publicado: (2021)

A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022
por: Stemler, Jannik, et al.
Publicado: (2022)

Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19
por: Meinberger, Denise, et al.
Publicado: (2021)

The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity
por: Keutmann, Matthias, et al.
Publicado: (2022)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for Microbiology
por: Stemler, Jannik, et al.
Publicado: (2021)

2383. Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: a randomised trial in adults ≥75 years (EU-COVAT-1) from the VACCELERATE consortium
por: Salmanton-Garcia, Jon, et al.
Publicado: (2023)

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
por: Stemler, Jannik, et al.
Publicado: (2023)

Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Sprute, Rosanne, et al.
Publicado: (2022)

P586: POTENTIAL DRUG-DRUG INTERACTIONS OF ANTIFUNGAL PROPHYLAXIS AND MIDOSTAURIN IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA – CLINICAL IMPLICATIONS OF THERAPEUTIC DRUG MONITORING
por: Joisten, Carolin, et al.
Publicado: (2023)

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
por: Christopeit, Maximilian, et al.
Publicado: (2020)

EQUAL CPA Score 2022: a tool to measure guideline adherence for chronic pulmonary aspergillosis
por: Sprute, Rosanne, et al.
Publicado: (2022)

Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-fumigatus Aspergillus spp.
por: Stemler, Jannik, et al.
Publicado: (2023)

COVID-19–Associated Pulmonary Aspergillosis, March–August 2020
por: Salmanton-García, Jon, et al.
Publicado: (2021)

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
por: Giesen, Nicola, et al.
Publicado: (2023)

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
por: Hoenigl, Martin, et al.
Publicado: (2021)

Protocol of the Cologne Corona Surveillance (CoCoS) Study– a prospective population-based cohort study
por: Oberste, Max, et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Hieber, Marie-Lisa, et al.
Publicado: (2022)

Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus
por: Henze, Larissa, et al.
Publicado: (2022)

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
por: Piechotta, Vanessa, et al.
Publicado: (2022)

2642. Multipathogen Antigen Test Kit (MAK-5) – Distribution and Frequency of Viral Respiratory Diseases in Germany among Volunteers in the VACCELERATE Registry
por: Nacov, Julia A, et al.
Publicado: (2023)

Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect
por: Schumacher, Sofie, et al.
Publicado: (2020)

Social determinants of health as drivers of fungal disease
por: Jenks, Jeffrey D., et al.
Publicado: (2023)

Results of the Cologne Corona surveillance (CoCoS) study – a prospective population-based cohort study: incidence data and potential underestimation of new SARS-CoV-2 adult infections by health authorities
por: Oberste, Max, et al.
Publicado: (2022)

Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals
por: Seidel, Danila, et al.
Publicado: (2021)

Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients (DOPPIO): Protocol for a Prospective Multicenter Study
por: Mellinghoff, Sibylle, et al.
Publicado: (2023)

Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020
por: Augustin, Max, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cgfb7i7tk8ia1o503eabqukdv2